Jaguar Health, Inc. filed a current report on Form 8-K on November 3, 2026, disclosing that its Series R Convertible Preferred Stock automatically converted into Common Stock on November 2, 2026, resulting in 13,345,986 shares of Common Stock issued and outstanding.
JPMorgan Chase Financial Company LLC filed a free writing prospectus on November 3, 2026, disclosing preliminary terms for 2.5-year Capped Dual Directional Buffered Equity Notes linked to the Nasdaq-100 Index and the S&P 500 Index, with a scheduled pricing date of November 24, 2026.
JPMorgan Chase Financial Company LLC filed a free writing prospectus (FWP) under Rule 433 on November 3, 2026, disclosing the summary terms of 2-year Capped Dual Directional Buffered Return Enhanced Notes linked to the Dow Jones Industrial Average and the S&P 500 Index, with …
JPMorgan Chase Financial Company LLC filed a free writing prospectus on November 3, 2026, disclosing preliminary terms for 18-month Capped Dual Directional Buffered Equity Notes linked to the Russell 2000 Index and the S&P 500 Index, with a scheduled pricing date of November 25, …
EEME Energy SPV I, LLC and Majique Ladnier filed Amendment No. 3 to a Schedule 13D with the SEC on November 3, 2026, disclosing updated beneficial ownership positions in the Class A Common Stock of XCF Global, Inc. and describing recent financing and strategic …
JPMorgan Chase Financial Company LLC filed a free writing prospectus (FWP) with the SEC for a structured note offering linked to three U.S. equity indexes, with a pricing date of November 24, 2026 and a maturity date of November 29, 2029.
JPMorgan Chase Financial Company LLC filed a free writing prospectus (FWP) under Rule 433 on November 3, 2026, disclosing the preliminary terms of three-year Uncapped Dual Directional Buffered Return Enhanced Notes linked to the Nasdaq-100 Index, Russell 2000 Index, and S&P 500 Index, with …
JPMorgan Chase Financial Company LLC filed a free writing prospectus (FWP) pursuant to Rule 433 disclosing preliminary terms for its 2-Year Russell 2000/S&P 500 Uncapped Dual Directional Buffered Return Enhanced Notes, with a Pricing Date of November 30, 2026 and Maturity Date of December …
JPMorgan Chase Financial Company LLC filed a free writing prospectus on November 3, 2026, disclosing the preliminary terms of 3-year uncapped dual directional buffered return enhanced notes linked to the Dow Jones Industrial Average, the Russell 2000 Index, and the S&P 500 Index, with …
JPMorgan Chase Financial Company LLC filed a free writing prospectus with the SEC for a three-year auto callable accelerated barrier note linked to the Nasdaq-100, Russell 2000, and S&P 500 indexes, with a pricing date of November 24, 2026 and a maturity date of …